Rose McCormack

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Jean‐Yves Douillard, Gyula Ostoros, Manuel Cobo et al. · Journal of Thoracic Oncology · 2014 · 445 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry, Sandra Pavey, Christine A. Pratilas et al. · Cancer Research · 2010 · 264 citations · Full text

Medicine, Oncology, Pharmacology +17

Remapping the Insulin Gene/<i>IDDM2</i> Locus in Type 1 Diabetes

Bryan J. Barratt, Felicity Payne, Chris Lowe et al. · Diabetes · 2004 · 223 citations

Life Sciences, Genetics, Molecular Genetics +17

Epidermal Growth Factor Receptor Mutation Status in Circulating Free DNA in Serum: From IPASS, a Phase III Study of Gefitinib or Carboplatin/Paclitaxel in Non-small Cell Lung Cancer

Kōichi Goto, Yukito Ichinose, Yuichiro Ohe et al. · Journal of Thoracic Oncology · 2011 · 210 citations · Full text

Medicine, Molecular Biology, Oncology +16

Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell–Free DNA from Patients with Advanced Non–Small Cell Lung Cancer

Guanshan Zhu, Xin Ye, Zhengwei Dong et al. · Journal of Molecular Diagnostics · 2015 · 201 citations · Full text

Medicine, Genetics, Oncology +16